Canine Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) ELISA Kit

Quantitative measurement of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in canine specimens is the focus of this Assay Genie ELISA kit, which supports apoptosis and oncology research in veterinary models. TRAIL, a type II transmembrane protein of the TNF superfamily, selectively triggers programmed cell death in transformed cell lines and is implicated in tumor immune surveillance.

Sample compatibility includes tissue homogenates and cell lysates, accommodating workflows that begin with solubilized proteins from cultured cells or biopsied material. Reactivity is specific to canine TRAIL, with the assay calibrated against recombinant canine antigen to limit cross-reactivity with related ligands or other species.

Each kit provides reagents for 96 assays, comprising pre-coated microplate wells, detection antibodies, recombinant standards, assay buffers, and a chromogenic substrate. The absorbance-based endpoint is read on a standard plate reader, and the protocol features short incubation steps to fit routine laboratory throughput. Intended for research use only, the kit serves studies of tumor biology, immune regulation, and apoptosis pathway characterization in canine disease models.